Lantheus Medical Imaging

Lantheus is a global leader in the field of medical imaging. We develop, manufacture and commercialize essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. Our pioneering products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography, nuclear imaging and magnetic resonance imaging (MRI) technologies.

Our products are routinely used to diagnose coronary artery disease (CAD), congestive heart failure (CHF), stroke, peripheral vascular (PVD) and other diseases.

In addition to our diversified portfolio of commercialized imaging agents and products, we have a strong development pipeline of internally-discovered next generation, first-in-class imaging agents that use positron emission tomography (PET), MRI technologies focused on enhancing current imaging modalities and fulfilling unmet diagnostic medical imaging needs.

Type
Public
HQ
Billerica, US
Founded
1956
Size (employees)
465 (est)-1%
Lantheus Medical Imaging was founded in 1956 and is headquartered in Billerica, US

Lantheus Medical Imaging Office Locations

Lantheus Medical Imaging has offices in Billerica, Montréal
Billerica, US (HQ)
331 Treble Cove Rd
Montréal, CA
600 1111 Boulevard Dr Frederik Philips

Lantheus Medical Imaging Metrics

Lantheus Medical Imaging Financial Metrics

Revenue (2016)

$301.9 m

Revenue growth (2015-16), %

3%

Gross profit

$137.8 m

Gross profit margin (2016), %

46%

Net income (2016)

$26.8 m

Market capitalization (21-Mar-2017)

$443.9 m

Closing share price (21-Mar-2017)

$12.3

Cash (31-Dec-2016)

$51.2 m
Lantheus Medical Imaging's current market capitalization is $443.9 m.
Lantheus Medical Imaging's revenue was reported to be $301.9 m in FY, 2016 which is a 2.9% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$283.7 m$301.6 m$293.5 m$301.9 m

Revenue growth, %

6%(3%)3%

Cost of goods sold

$206.3 m$176.1 m$157.9 m$164.1 m

Gross profit

$77.4 m$125.5 m$135.5 m$137.8 m

Gross profit Margin, %

27%42%46%46%

Sales and marketing expense

$34.7 m$36.5 m

R&D expense

$14.4 m$12.2 m

General and administrative expense

$43.9 m$38.8 m

Operating expense total

$96.4 m$83.7 m$93 m$87.6 m

EBIT

($19 m)$41.8 m$42.5 m$56.6 m

EBIT margin, %

(7%)14%14%19%

Interest expense

$42.9 m$42.3 m($38.7 m)($26.6 m)

Interest income

$104 k$27 k$24 k

Pre tax profit

($60.7 m)$26 k($11.8 m)$28.3 m

Income tax expense

$1 m$1.2 m$3 m$1.5 m

Net Income

($61.7 m)($1.2 m)($14.7 m)$26.8 m
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$16.7 m$17.8 m$28.6 m$51.2 m

Accounts Receivable

$38.9 m$41.5 m$13.7 m

Inventories

$18.3 m$15.6 m$17.2 m

Current Assets

$77.3 m$79.2 m$90.1 m$110.8 m

PP&E

$97.7 m$96 m$86.5 m

Goodwill

$15.7 m$15.7 m$15.7 m$15.7 m

Total Assets

$259.4 m$247.5 m$242.4 m$255.9 m

Accounts Payable

$18.1 m$15.7 m

Total Debt

$11.7 m

Current Liabilities

$55.6 m$48.5 m$35.7 m$43.8 m

Common Stock

$303 k$367 k

Additional Paid-in Capital

$2.9 m$3.9 m$175.6 m$226.5 m

Retained Earnings

($238.3 m)($239.5 m)($359.2 m)($332.4 m)

Total Equity

($185.3 m)($106.5 m)

Debt to Equity Ratio

-0.1 x

Debt to Assets Ratio

0 x

Financial Leverage

-1.3 x-2.4 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($61.7 m)($1.2 m)($14.7 m)$26.8 m

Depreciation and Amortization

$9.3 m$9.9 m$19.7 m$18.3 m

Accounts Receivable

$2.6 m($3.6 m)($2.5 m)

Inventories

$1 m($882 k)$121 k

Accounts Payable

($1.1 m)($4 m)

Cash From Operating Activities

$49.6 m

Capital Expenditures

($5 m)($8.1 m)($13.2 m)($7.4 m)

Cash From Investing Activities

$3.3 m

Long-term Borrowings

($1.9 m)($78.7 m)

Cash From Financing Activities

($30.2 m)

Interest Paid

$39.2 m$39.2 m$40.8 m$24.4 m

Income Taxes Paid

$187 k($112 k)

Free Cash Flow

$42.2 m

Lantheus Medical Imaging Market Value History

Lantheus Medical Imaging Company Life

You may also be interested in